Researchers say ‘relatively simple, inexpensive’ means of assessing genetic risk offers hope of better screening
An at-home spit test appears to perform better at predicting prostate cancer risk than the current frontline test, a study suggests.
The test assesses 130 genetic variants to provide a risk score for prostate cancer, which is the second most common cause of cancer deaths in men in the UK.
More Stories
Scientists record seismic tremors from title-clinching Liverpool win over Spurs
Tech oligarchs are gambling our future on a fantasy | Adam Becker
Elon Musk’s company town: SpaceX employees to vote on ‘Starbase’